Safety of Concurrent Administration of Ozanimod and Serotonergic Antidepressants in Patients with Relapsing Multiple Sclerosis

被引：0
|
作者：
Naismith, R. T. [1 ]
Cohen, J. A. [2 ]
Bar-Or, A. [3 ,4 ]
Comi, G. [5 ]
Selmaj, K. W. [6 ,7 ]
Hartung, H. [8 ]
Sheffield, J. K. [9 ]
Minton, N. [9 ]
Gleichmann, M. [9 ]
Liu, H. [9 ]
Riolo, J. [9 ]
Silva, D. [9 ]
Cree, B. A. [10 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Cleveland Clin, Mellen Ctr MS Treatment & Res, Cleveland, OH 44106 USA
[3] Univ Penn, Perelman Sch Med, Ctr Neuroinflammat & Expt Therapeut, Philadelphia, PA 19104 USA
[4] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA
[5] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Dept Neurol, Milan, Italy
[6] Ctr Neurol, Lodz, Poland
[7] Univ Warmia & Mazury, Dept Neurol, Coll Med, Olsztyn, Poland
[8] Heinrich Heine Univ, Fac Med, Dept Neurol, Dusseldorf, Germany
[9] Bristol Myers Squibb, Princeton, NJ USA
[10] Univ Calif San Francisco, Dept Neurol, Weill Inst Neurosci, San Francisco, CA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P080
引用
收藏
页码：53 / 54
页数：2
相关论文
共 50 条
  • [21] Hepatic safety of ozanimod in relapsing multiple sclerosis in the DAYBREAK open-label extension study
    Selmaj, K.
    Steinman, L.
    Comi, G.
    Bar-Or, A.
    Hartung, H. -P.
    Montalban, X.
    Havrdova, E. K.
    Sheffield, J. K.
    Minton, N.
    Afsari, S.
    Shi, F.
    Kappos, L.
    Cohen, J. A.
    Cree, B. A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 608 - 609
  • [22] Safety and Efficacy of Ozanimod Over 1 Year in Patients with Early Relapsing Multiple Sclerosis: an Interim Analysis of the ENLIGHTEN Study
    Naismith, Robert
    Zivadinov, Robert
    Morrow, Sarah
    Bass, Ann
    Obeidat, Ahmed Zayed
    Riser, Emily
    Wray, Sibyl
    Cristofanilli, Massimiliano
    Riolo, Jon
    Thorpe, Andrew
    Chaudhry, Burhan
    Mohiuddin, Kamran
    Cheng, Chun-Yen
    Silva, Diego
    DeLuca, John
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 596 - 597
  • [23] Safety patterns with ozanimod during phase 3 and open-label extension trials in patients with relapsing multiple sclerosis
    Selmaj, K. W.
    Ziemssen, T.
    Comi, G.
    Hartung, H. -P.
    Singal, M.
    Riolo, J. V.
    Cheng, C. -Y.
    Sheffield, J. K.
    Minton, N.
    Vermersch, P.
    Cree, B. A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 641 - 642
  • [24] Ozanimod in relapsing forms of multiple sclerosis: a profile of its use
    Shirley, Matt
    DRUGS & THERAPY PERSPECTIVES, 2021, 37 (04) : 143 - 149
  • [25] Ozanimod in relapsing forms of multiple sclerosis: a profile of its use
    Matt Shirley
    Drugs & Therapy Perspectives, 2021, 37 : 143 - 149
  • [26] Comparative efficacy and safety of ozanimod and ponesimod for relapsing multiple sclerosis: A matching-adjusted indirect comparison
    Swallow, Elyse
    Pham, Timothy
    Patterson-Lomba, Oscar
    Yin, Lei
    Gomez-Lievano, Andres
    Liu, Jingyi
    Tencer, Tom
    Gupte-Singh, Komal
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 71
  • [27] Update on Hepatic Safety of Ozanimod in Relapsing Multiple Sclerosis in the DAYBREAK Open-Label Extension Trial
    Selmaj, K. W.
    Steinman, L.
    Comi, G.
    Bar-Or, A.
    Hartung, H. P.
    Montalban, X.
    Havrdova, E. K.
    Sheffield, J. K.
    Thorpe, A.
    Riolo, J. V.
    Krakovich, A.
    Cheng, C. Y.
    Kappos, L.
    Cohen, J. A.
    Cree, B. A. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 325 - 326
  • [28] Cardiac safety profile of ozanimod in pooled phase 3 studies in relapsing multiple sclerosis (SUNBEAM and RADIANCE)
    Cree, B. A. C.
    Comi, G.
    Mendzelevski, B.
    Skolnick, B. E.
    Agafonova, N.
    Ding, N.
    Minton, N.
    Sheffield, J. K.
    Kleiman, R.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 266 - 267
  • [29] COMPARATIVE EFFICACY AND SAFETY OF OZANIMOD AND PONESIMOD FOR RELAPSING MULTIPLE SCLEROSIS: A MATCHING-ADJUSTED INDIRECT COMPARISON
    Swallow, E.
    Pham, T.
    Patterson-Lomba, O.
    Yin, L.
    Gomez-Lievano, A.
    Liu, J.
    Tencer, T.
    Gupte-Singh, K.
    VALUE IN HEALTH, 2022, 25 (07) : S300 - S300
  • [30] Long-term Safety of Ozanimod in Relapsing Multiple Sclerosis and Moderately to Severely Active Ulcerative Colitis
    Cree, Bruce A. C.
    Danese, Silvio
    Wolf, Douglas C.
    Alekseeva, Olga
    Charles, Lorna
    Petersen, AnnKatrin
    Sheffield, James K.
    Cheng, Chun-Yen
    Riolo, Jon V.
    Silva, Diego
    Lublin, Fred D.
    Rubin, David T.
    Cohen, Jeffrey A.
    NEUROLOGY, 2023, 100 (17)
12345